|
Real-time Estimate
Cboe Europe
16:19:46 30/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 133.49 CHF | +0.90% |
|
+4.56% | +22.12% |
| 10-30 | Bristol Myers raises 2026 revenue forecast, lowers EPS due to charge | RE |
| 10-30 | Bristol Myers raises 2026 revenue forecast, lowers EPS due to charge | RE |
| Market Cap | 302B 271B 250B 226B 423B 28,794B 430B 2,981B 1,189B 15,070B 1,135B 1,111B 47,729B | P/E 2026 * |
22.9x | P/E 2027 * | 18.6x |
|---|---|---|---|---|---|
| Enterprise Value | 338B 303B 279B 253B 473B 32,188B 480B 3,332B 1,329B 16,845B 1,269B 1,242B 53,354B | EV / Sales 2026 * |
5.89x | EV / Sales 2027 * | 5.39x |
| Free-Float |
91.66% | Yield 2026 * |
2.75% | Yield 2027 * | 2.87% |
| Markets | Quality | ||
|---|---|---|---|
Swiss Exchange
| NOVN | Delayed | |
Borsa Italiana
| 1NOVN | End-of-day quote | |
|
Xetra
| NOT | End-of-day quote | |
|
Xetra
| NOT | Delayed | |
|
CBOE
| 0QLR | Real-time | |
|
Deutsche Boerse AG
| NOT | End-of-day quote | |
|
OTC Markets
| NVSEF | Delayed | |
|
Tradegate
| NOT | Real-time | |
|
Mexican S.E.
| NOVN N | End-of-day quote | |
|
Deutsche Boerse AG
| NOT | Delayed | |
|
Boerse Muenchen
| NOT | Real-time | |
|
CBOE
| Real-time | ||
|
CBOE
| 0QLR | Real-time | |
|
London S.E.
| 0QLR | Delayed | |
|
Börse Stuttgart
| NOT | Delayed | |
|
Wiener Boerse
| NOVN | End-of-day quote |
Last Transcript: Novartis AG
| 1 day | +0.90% | ||
| 1 week | +4.56% | ||
| Current month | +11.57% | ||
| 1 month | +11.57% | ||
| 3 months | +5.57% | ||
| 6 months | +15.48% | ||
| Current year | +22.12% |
| 1 week | 125.38 |  | 134.5 |
| 1 month | 115.94 | | 134.5 |
| Current year | 107.68 | | 134.5 |
| 1 year | 98.61 | | 134.5 |
| 3 years | 81.1 | | 134.5 |
| 5 years | 72.84 | | 134.5 |
| 10 years | 65.09 | | 134.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 01/02/2018 | |
Mukul Mehta
DFI | Director of Finance/CFO | - | 16/03/2026 |
Karen Hale
CMP | Compliance Officer | 58 | 14/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Nancy Andrews
BRD | Director/Board Member | 67 | 01/01/2015 |
| Director/Board Member | 69 | 01/01/2016 | |
Ton Büchner
BRD | Director/Board Member | 61 | 01/01/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 18/5/26 | Sell | -5,200 | 0.0003% | |||
| 4/5/26 | Sell | 6,800 | 0.0003% | |||
| 17/2/26 | Sell | 30,743 | 0.0015% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.89% | +4.56% | +35.36% | +58.15% | 302B | |
| +6.63% | +5.13% | +68.86% | +145.20% | 1,224B | |
| +1.53% | +2.84% | +47.48% | +89.01% | 662B | |
| +1.68% | +1.96% | +29.16% | +109.31% | 514B | |
| +0.66% | +3.53% | +54.64% | +67.72% | 388B | |
| +3.83% | -0.62% | +69.01% | +42.32% | 361B | |
| +3.39% | +5.07% | +7.40% | +31.87% | 271B | |
| +1.97% | +3.01% | +57.91% | +76.14% | 249B | |
| +4.03% | +5.36% | +39.76% | +116.14% | 205B | |
| +1.47% | +1.79% | -17.94% | -60.93% | 172B | |
| Average | +2.20% | +2.17% | +39.16% | +67.49% | 434.88B | |
| Weighted average by Cap. | +2.19% | +2.85% | +48.06% | +90.35% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 57.34B 51.36B 47.38B 42.88B 80.18B 5,460B 81.47B 565B 226B 2,858B 215B 211B 9,051B | 61.43B 55.02B 50.76B 45.94B 85.9B 5,850B 87.29B 606B 242B 3,062B 231B 226B 9,697B |
| Net income | 14.2B 12.72B 11.74B 10.62B 19.86B 1,352B 20.18B 140B 55.86B 708B 53.3B 52.17B 2,242B | 16.34B 14.63B 13.5B 12.22B 22.84B 1,556B 23.21B 161B 64.26B 814B 61.31B 60.01B 2,579B |
| Net Debt | 35.63B 31.92B 29.44B 26.64B 49.82B 3,393B 50.63B 351B 140B 1,776B 134B 131B 5,624B | 28.51B 25.54B 23.56B 21.32B 39.86B 2,715B 40.51B 281B 112B 1,421B 107B 105B 4,500B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | CHF 133.78 | +1.12% | 513,119 |
| 29/10/26 | CHF 132.30 | +2.38% | 6,118,905 |
| 28/10/26 | CHF 129.22 | +0.34% | 2,941,763 |
| 27/10/26 | CHF 128.78 | +1.02% | 5,166,869 |
| 26/10/26 | CHF 127.48 | -0.41% | 3,433,560 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NOVN Stock
Select your edition
All financial news and data tailored to specific country editions
